World's Best Scientists 2026 revealed!
Gail E. Sonenshein

Gail E. Sonenshein

D-Index & Metrics

Molecular Biology

D-Index
82
Citations
20127
World Ranking
944
National Ranking
501

Gail E. Sonenshein publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Gail E. Sonenshein sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 178 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Gail E. Sonenshein D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Gail E. Sonenshein sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2009 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Gail E. Sonenshein is affiliated with Tufts University in the United States. Their research spans several interconnected fields within medicine, with a particular focus on oncology and related disciplines. The main fields of study include Medicine, with subfields concentrating on Oncology, Immunology and Allergy, Cancer Research, and Radiology, Nuclear Medicine and Imaging.

The research topics primarily address molecular and cellular aspects of cancer, especially breast cancer. Major topics of work include HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research, Breast Cancer Treatment Studies, and Monoclonal and Polyclonal Antibodies Research.

The scientist has coauthored papers with several collaborators. Frequent coauthors include Stefania Pianetti, Nora D. Mineva, Kathy D. Miller, Hannah H. Chen, and Sandra K. Althouse.

Publication venues for recent work include Cancer Cell International and Pharmaceutics. The following notable papers have been published:

  • ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients, 2023, Cancer Cell International
  • A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer, 2024, Pharmaceutics

These studies address the role of ADAM8 in breast cancer pathology and the development of inhibitory antibodies as potential treatments, reflecting a focus on translational cancer research.

Gail E. Sonenshein was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS) in 2009. This designation marks recognition within the scientific community associated with their career and contributions.

Best Publications

  • Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

    Mika A. Sovak;Robert E. Bellas;Dong W. Kim;Gregory J. Zanieski

  • Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation

    Judith Campisi;Harry E. Gray;Arthur B. Pardee;Michael Dean

  • Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.

    M Wu;H Lee;R E Bellas;S L Schauer

  • NF-κB and epithelial to mesenchymal transition of cancer†

    Chengyin Min;Sean F. Eddy;Sean F. Eddy;David H. Sherr;David H. Sherr;Gail E. Sonenshein;Gail E. Sonenshein

  • Protein kinase CK2 in mammary gland tumorigenesis.

    Esther Landesman-Bollag;Raphaëlle Romieu-Mourez;Diane H Song;Gail E Sonenshein

  • Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.

    F A La Rosa;J W Pierce;G E Sonenshein

  • Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.

    Stefania Pianetti;Marcello Arsura;Marcello Arsura;Raphaëlle Romieu-Mourez;Robert J Coffey

  • Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.

    William Yang;Jian Shen;Min Wu;Marcello Arsura

  • The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c- myc promoter in mammary cells

    Dong W. Kim;Lee Gazourian;Shafat A. Quadri;Raphaëlle Romieu-Mourez

  • TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα

    Marcello Arsura;Min Wu;Gail E Sonenshein

  • Notch1 augments NF-κB activity by facilitating its nuclear retention

    Hyun Mu Shin;Lisa M Minter;Ok Hyun Cho;Sridevi Gottipati

  • Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.

    Mabel P. Duyao;Alan J. Buckler;Gail E. Sonenshein

  • Rel/NF-κB transcription factors and the control of apoptosis

    Gail E. Sonenshein

  • Green tea extracts decrease carcinogen‐induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture

    Kathryn T. Kavanagh;Laurie J. Hafer;Dong W. Kim;Koren K. Mann

  • Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact

    M Dean;R A Levine;W Ran;M S Kindy

  • Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.

    Xiaohui Yu;Susan Dluz;Dana T. Graves;Lei Zhang

  • Green Tea Polyphenol Epigallocatechin-3 Gallate Inhibits Her-2/Neu Signaling, Proliferation, and Transformed Phenotype of Breast Cancer Cells

    Stefania Pianetti;Shangqin Guo;Kathryn T. Kavanagh;Gail E. Sonenshein

  • Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2

    Xiaobo Wang;Karine Belguise;Nathalie Kersual;Kathrin H. Kirsch

  • Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.

    R E Bellas;J S Lee;G E Sonenshein

  • Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle.

    C F Reilly;M S Kindy;K E Brown;R D Rosenberg

Frequent Co-Authors

Philip C. Trackman
Philip C. Trackman Boston University
David C. Seldin
David C. Seldin Boston University
David H. Sherr
David H. Sherr Boston University
Michael Dean
Michael Dean National Institutes of Health
Carl Franzblau
Carl Franzblau Boston University
Thomas L. Rothstein
Thomas L. Rothstein Western Michigan University
George Brawerman
George Brawerman Tufts University
Mark S. Kindy
Mark S. Kindy University of South Florida
Snorri S. Thorgeirsson
Snorri S. Thorgeirsson National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in molecular biology, there are several online degree options in the broader life sciences and healthcare fields that can expand your career options. For example, nurses looking to advance their qualifications can explore asn to fnp programs, which provide an accelerated route to become a family nurse practitioner. These programs are designed to bridge the gap for those holding an associate degree in nursing.

For those without a nursing background but interested in healthcare, there are direct entry msn programs for non-nurses online that allow individuals from other disciplines—such as molecular biology—to transition into nursing and advanced clinical roles.

When selecting a program, it’s important to compare educational quality, cost, and flexibility. Interested learners should review options like the chamberlain vs capella rn to bsn program comparison to make informed decisions about where to enroll.

Finally, working RNs can consider affordable bsn to msn online programs to further specialize and expand their career horizons. Each pathway offers unique advantages for those passionate about science and healthcare.

Best Scientists Citing Gail E. Sonenshein

Trending Scientists

Recently Published Articles